In the past 12 hours, Jordan’s humanitarian response to Lebanon remains the dominant Jordan-related thread. Multiple reports say Jordan Hashemite Charity Organisation (JHCO) convoys are continuing: Jordan sent an 18-truck aid convoy to Lebanon (described as the fourth such mission), and JHCO also said it is preparing a fourth convoy, bringing the total to four convoys and 78 trucks carrying medicines, medical supplies, infant formula, relief items, and kitchen equipment. The coverage frames this as sustained support amid a deteriorating humanitarian situation in Lebanon following the collapse of the November 2024 ceasefire and subsequent escalation.
Alongside the aid logistics, the most urgent funding pressure highlighted in the last 12 hours concerns UNRWA. A UNRWA media adviser warned the agency faces a financial deficit estimated at $100 million–$200 million, saying current funding would only sustain operations until the end of August unless urgent financing is secured. The same report emphasizes the scale of operational strain—especially in Gaza, where around 90% of UNRWA facilities are described as damaged—and the need to cover salaries for nearly 30,000 employees and contractors while maintaining education and healthcare services.
There is also a notable health-and-industry angle in the last 12 hours, but it is more “sector progress” than immediate policy change. Yarmouk University secured a U.S. patent for pharmaceutical manufacturing technology aimed at improving production efficiency and reducing environmental impact, including a solvent-free approach to dry coating. In parallel, an INTERPOL-coordinated global operation reported seizures of 6.42 million doses of unapproved/counterfeit pharmaceuticals worth USD 15.5 million, underscoring ongoing risks from illicit medicines—though this is not presented as Jordan-specific in the provided text.
Looking beyond the most recent 12 hours, earlier coverage provides continuity on Jordan’s broader regional pressures and humanitarian context. Reports in the 3–7 day window include Jordan’s ongoing lifeline to Gaza through child medical evacuations and references to large-scale refugee returns, while other items point to Jordan’s policy and infrastructure steps (e.g., cabinet approval of railway licensing bylaw and truck fleet incentives). However, the evidence in the provided set is sparse on direct “health system” developments in Jordan itself beyond the Yarmouk patent and the UNRWA funding warning—so the clearest change in the last day is the renewed emphasis on Lebanon aid delivery and the immediate funding gap facing UNRWA.